Patient Quality of Recovery After TAVR With Different Sedation Regimens

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.

Also called NCT07556523

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
David Lyubashevsky (from the registry)
Registry
  • NCT NCT07556523
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07556523. Randomized; double masking; primary purpose treatment. Start 2026-03-16 (actual); primary completion 2028-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Patient Quality of Recovery After TAVR With Different Sedation Regimens
Condition
Aortic Valve Stenosis
Intervention (Drug)
Propofol
Intervention (Drug)
Dexmedetomidine
Intervention (Drug)
Midazolam
Intervention (Drug)
Fentanyl
Lead sponsor
David Lyubashevsky (class: other)

Record details

Record id
cardio:ct-nct07556523
Content hash
758412bca30975f8d8c4c8a96d3b85152dbf978f20d6b72681cf8ddf97c6fb5d